Who Paid My Doc
John Perfect
Infectious Disease Durham, NC Medical Doctor
NPI 1487717260 CMS profile 1258922
330 Trent Dr, 163 Hanes House, Durham, NC 27710
General payments
$5,828
Research payments
$1,400
Ownership & investment interest
$0
Research they led as principal investigator
$178,125
Through program year 2023, John Perfect of Durham, NC is reported in the CMS Open Payments database as having received $5,828 across 6 general payments and $1,400 in research payments paid to them. Separately, studies naming them as principal investigator received $178,125 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 85th percentile of Infectious Disease profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $1,150 | 3 | |
| 2023 | Research | $1,400 | 1 | |
| 2022 | General | $1,750 | 2 | |
| 2019 | General | $2,928 | 1 |
Beside peers
- John Perfect
- Infectious Disease median
- Middle half of Infectious Disease
- National median
In program year 2025, general payments to John Perfect were reported at $0. Among 3,905 Infectious Disease profiles paid that year, the median was $188 and the middle half received between $57 and $766.
Show as a table
| Year | John Perfect | Infectious Disease median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $2,928 | $190 | $60–$862 | $163 |
| 2020 | $0 | $124 | $32–$606 | $114 |
| 2021 | $0 | $148 | $38–$905 | $132 |
| 2022 | $1,750 | $166 | $50–$834 | $149 |
| 2023 | $1,150 | $171 | $57–$787 | $160 |
| 2024 | $0 | $176 | $52–$752 | $164 |
| 2025 | $0 | $188 | $57–$766 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 7 billing codesPaid by Medicare
$3,195
Medicare patients
13
Services billed
47
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
7 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Infectious Disease in North Carolina
David Wohl
Infectious Disease · Chapel Hill, NC
Cristina Gasparetto
Infectious Disease · Durham, NC
Cornelius Van Dam
Infectious Disease · Greensboro, NC
William Harley
Infectious Disease · Charlotte, NC
Joseph Eron
Infectious Disease · Chapel Hill, NC
William Alexander
Infectious Disease · Cary, NC
Related records
Infectious Disease in North Carolina
Practitioners in the same specialty and state, ranked by reported value.
All Infectious Disease
Everyone recorded under this specialty, nationwide.
Doctors in North Carolina
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.